Effect on KATP channel activation properties and tissue selctivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine
Boverie, S.; Antoine, M.-H.; Somers, F.et al.
2005 • In Journal of Medicinal Chemistry, 48, p. 3492-3503
Counerotte, Stéphane ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Pirotte, Bernard ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Lebrun, P.
De Tullio, Pascal ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Language :
English
Title :
Effect on KATP channel activation properties and tissue selctivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine
Publication date :
2005
Journal title :
Journal of Medicinal Chemistry
ISSN :
0022-2623
eISSN :
1520-4804
Publisher :
American Chemical Society, Washington, United States - District of Columbia
Bryan, J.; Aguilar-Bryan, L. The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle. Curr. Opin. Cell. Biol. 1997, 9, 553-559
Cook, N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol. Sci. 1988, 9, 21-28.
Noma, A. ATP-regulated K+ channels in cardiac muscle. Nature 1983, 305, 147-148.
Cook, D. L.; Hales, C. N. Intracellular ATP directly blocks K+ channels in pancreatic B-cells, Nature 1984, 311, 271-273.
Allard, B.; Lazdunski, M. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells. Eur. J. Pharmacol. 1993, 236, 419-426.
Standen, N. B.; Quayle, J. M.; Davies, N. W.; Brayden, J. E.; Huang, Y.; Nelson, M. T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 1989, 245, 177-180.
Quayle, J. M.; Nelson, M. T.; Standen, N. B. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol. Rev. 1997, 77, 1165-1232.
Bernardi, H.; A., Fosset, M.; Lazdunski, M. Purification and affinity labeling of a brain [3H] glibenclamide binding protein, a putative neuronal ATP-regulated K+ channel. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 9816-9820.
Lebrun, P.; Devreux, V.; Hermann, M.; Herchuelz, A. Pinacidil inhibits insulin release by increasing K+ outflow from pancreatic B-cells. Eur. J. Pharmacol. 1988, 156, 283-286.
Lebrun, P.; Devreux, V.; Hermann, M.; Herchuelz, A. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets. J. Pharmacol. Exp. Ther. 1989, 250, 1011-1018.
Hamilton, T. C.; Weston, A. H. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen. Pharmacol. 1989, 20, 1-9.
Lebrun, P.; Arkhammar, P.; Antoine, M.-H.; Nguyen, Q.-A.; Hansen, J. B.; Pirotte, B. A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release. Diabetologia 2000, 43, 723-732.
Cook, N. S.; Quast, U. Potassium channel pharmacology. In Potassium channels, structure, classification, function and therapeutic potential; Cook, N. S., Ed.; Ellis Horwood: Chichester U. K, 1990; pp 181-255.
Björk, E.; Berne, C.; Kämpe, O.; Wibell, P.; Oskarsson, F. A. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 1996, 45, 1247-1430.
Alemzadeh, R.; Langley, G.; Upchurch, L.; Smith, P.; Slonim, A. E. Beneficial effect of diazoxide in obese hyperinsulinemic adults. J. Clin. Endocrinol. Metabol. 1998, 83, 1911-1915.
Babenko, A. P.; Aguilar-Bryan, L.; Bryan, J. A view of SUR/Kir X K ATP channels. Annu. Rev. Physiol. 1998, 60, 667-687.
D'hahan, N.; Moreau, C.; Prost, A. L.; Jacquet, H.; Alekseev, A. E.; Terzic, A.; Vivaudou, M. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 12162-12167.
Babenko, A. P.; Gonzalez, G.; Aguilar-Bryan, L.; Bryan, J. Reconstructed human cardiac K-ATP channels-functional identity with the native channels from the sarcolemma of human ventricular cells. Circ. Res. 1998, 83, 1132-1143.
D'hahan, N.; Jacquet, H.; Moreau, C.; Catty, P.; Vivaudou, M. A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K+ channels by K+ channel openers. Mol. Pharmacol. 1999, 56, 308-315.
Inagaki, N.; Gonoi, T.; Clement, J. P.; Namba, N.; Inazawa, J.; Gonzalez, G.; Aguilar-Bryan, L.; Seino, S.; Bryan, J. Reconstitution of I-K ATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995, 270, 1166-1170.
Inagaki, N.; Gonoi, T.; Clement, J. P.; Wang, C. Z.; Aguilar-Bryan, L.; Bryan, J.; Seino, S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 1996, 16, 1011-1017.
Isomoto, S.; Kondo, C.; Yamada, M.; Matsumoto, S.; Higashiguchi, O.; Horio, Y.; Matsuzawa, Y.; Kurachi, Y. A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J. Biol. Chem. 1996, 271, 24321-24324.
Pirotte, B.; Antoine, M.-H.; de Tullio, P.; Hermann, M.; Herchuelz, A.; Delarge, J.; Lebrun, P. A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels. Biochem. Pharmacol. 1994, 47, 1381-1386
de Tullio, P.; Pirotte, B.; Lebrun, P.; Fontaine, J.; Dupont, L.; Antoine, M.-H.; Ouedraogo, R.; Khelili, S.; Magetto, C.; Masereel, B.; Diouf, O.; Podona, T.; Delarge, J. 3- and 4-substituted 4H-pyrido[4,3-e]-1,2,4- thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation and structure - activity relationships. J. Med. Chem. 1996, 39, 937-948.
Boverie, S.; Antoine, M.-H.; de Tullio, P.; Somers, F.; Becker, B.; Sebille, S.; Lebrun, P.; Pirotte, B. Effect on insulin release of compounds structurally related to the potassium channel opener 7-chloro-3-isopropylamino- 4H-1,2,4-benzothiadiazine 1,1-dioxide (BPDZ 73): introduction of heteroatoms on the 3-alkylamino side chain of the benzothiadiazine 1,1-dioxide ring. J. Pharm. Pharmacol. 2001, 53, 973-980.
de Tullio, P.; Becker, B.; Boverie, S.; Dabrowski, M.; Wahl, P.; Antoine, M.-H.; Somers, F.; Sebille, S.; Ouedraogo, R.; Bondo Hansen, J.; Lebrun, P.; Pirotte, P. Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides. J. Med. Chem. 2003, 46, 3342-3353.
Girard, Y.; Atkinson, J. G.; Rokach, J. A new synthesis of 1,2,4-benzothiadiazine and selective preparation of o-aminobenzene-sulfonamides. J. Chem. Soc., Perkin Trans. 1 1979, 1043-1047.
Di Bella, M.; Rinaldi, M.; Fabio, U.; Manicardi, G. Azione antimicrobica di derivati dell' 1,2,4-benzothiadiazine-1,1-diossido. Il Farmaco 1972, 27, 990-998.
de Tullio, P.; Pirotte, B.; Somers, F.; Boverie, S.; Lacan, F.; Delarge, J. Study of the ring closure reaction of o-aminoaryl-sulfonamides with 1, 1′-thiocarbonyldiimidazole. Tetrahedron 1998, 54, 4935-4942.
Nielsen, F. E.; Bodvarsdottir, T. B.; Worsaae, A.; MacKay, P.; Stidsen, C. E.; Boonen, H. C., Pridal, L.; Arkhammar, P. O.; Wahl, P.; Ynddal, L.; Junager, F.; Dragsted, N.; Tagmose, T. M.; Mogensen, J. P.; Koch, A.; Treppendahl, S. P.; Hansen, J. B. 6-Chloro-3-alkylamino-4H-thieno[3, 2-e]-1,2,4-benzothiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic B-cells. J. Med. Chem. 2002, 45, 4171-4187.
Somers, F.; De Tullio, P.; Boverie, S.; Dogné, J. M.; De Leval, X.; Antoine, M.-H.; Lebrun, P.; Pirotte, B. Synthesis and biological effects of new 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides on insulin-secreting cells. Pharm. Pharmacol. Commun. 2000, 6, 89-95.
Hansch, C.; Leo, A.; Unger, S. H.; Ki Hwan Kim; Nikaitani, D.; Lien, E. J. "Aromatic" substituent constants for structure - activity correlation. J. Med. Chem. 1973, 16, 1207-1216.
Manley, P. W.; Quast, U. Structure - activity studies of potassium channel opening in pinacidil-like cyanoguanidines, nitroethenediamines, thioureas, and ureas. J. Med. Chem. 1992, 35, 2327-2340.
de Tullio, P.; Pirotte, B.; Dupont, L.; Masereel, B.; Laeckmann, D.; Podona, T.; Diouf, O.; Lebrun, P.; Delarge, J. Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-pyridothiadiazine 1,1-dioxides, pyridyl analogues of 1,2,4-benzothiadiazine 1,1-dioxides. Tetrahedron 1995, 51, 3221-3234.
Dabrowski, M.; Ashcroft, F. M.; Ashfield, R.; Lebrun, P.; Pirotte, B.; Egebjerg, J.; Hansen J. B.; Wahl, P. The novel diazoxide analogue 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Diabetes 2002, 51, 1896-1906.
Pitzer, K. K.; Werbovets, K. A.; Brendle, J. J.; Scovill, J. P. Synthesis and biological evaluation of 4-chloro-3,5-dinitrobenzotrifluoride analogues as antileishmanial agents. J. Med. Chem. 1998, 41, 4885-4889.
Jackman, G. B.; Petrow, V.; Stephenson, O.; Wild, A. M. Studies in the field of diuretic agents. Part VI: some sulphamoylbenzoic acids. J. Pharm. Pharmacol. 1962, 679-686.
Raffa, L.; Di Bella, M.; Melegari, M.; Vampa, G. Ricerce nel campo della 1,2,4-benzotiadiazina, Nota XXI - Derivati del 3-amino-1,2,4-benzotiadiazin-1,1- diossido. Il Farmaco 1862, XVII, 331-339.
Peat, A. J.; Towsen, C.; Worley, J. F.; Scott, H. A.; Garrido, D.; Mertz, R. J.; Pfohl, J. L.; Terry, C. M.; Truax, J. F.; Veasey, R. L.; Thomson, S. A. Synthesis and evaluation of 7-substituted-3-cyclobutylamino-4H-1,2,4- benzothiadiazines as KATP channel agonists. Bioorg. Med. Chem. Lett. 2002, 12, 2977-2980.
Albert, A.; Serjeant, E. P. The determination of ionization constants; Chapman & Hall: London, 1971; pp 44-64.
Leclerq-Meyer, V.; Marchand, J.; Woussen-Cole, M. C.; Giroix, M.-H.; Malaisse, W. J. Multiple effects of leucine on glucagons, insulin and somatostatin secretion from the perfused rat pancreas. Endocrinology 1985, 116, 1168-1174.
